Article Versions Notes

Cojutti PG, Tedeschi S, Gatti M, Zamparini E, Meschiari M, Siega PD, Mazzitelli M, Soavi L, Binazzi R, Erne EM, et al. Population Pharmacokinetic and Pharmacodynamic Analysis of Dalbavancin for Long-Term Treatment of Subacute and/or Chronic Infectious Diseases: The Major Role of Therapeutic Drug Monitoring. Antibiotics. 2022; 11(8):996. https://doi.org/10.3390/antibiotics11080996

Cojutti, Pier Giorgio, Sara Tedeschi, Milo Gatti, Eleonora Zamparini, Marianna Meschiari, Paola Della Siega, Maria Mazzitelli, Laura Soavi, Raffaella Binazzi, Elke Maria Erne, and et al. 2022. "Population Pharmacokinetic and Pharmacodynamic Analysis of Dalbavancin for Long-Term Treatment of Subacute and/or Chronic Infectious Diseases: The Major Role of Therapeutic Drug Monitoring" Antibiotics 11, no. 8: 996. https://doi.org/10.3390/antibiotics11080996

Cojutti, P. G., Tedeschi, S., Gatti, M., Zamparini, E., Meschiari, M., Siega, P. D., Mazzitelli, M., Soavi, L., Binazzi, R., Erne, E. M., Rizzi, M., Cattelan, A. M., Tascini, C., Mussini, C., Viale, P., & Pea, F. (2022). Population Pharmacokinetic and Pharmacodynamic Analysis of Dalbavancin for Long-Term Treatment of Subacute and/or Chronic Infectious Diseases: The Major Role of Therapeutic Drug Monitoring. Antibiotics, 11(8), 996. https://doi.org/10.3390/antibiotics11080996